Investorideas.com Newswire

Investorideas.com Newswire
Be one of the most talked about companies (stocks) on social media

Investorideas.com newswire, biotech stocks and industry

Friday, November 12, 2010

Biotech Stocks Trading Alert ; (OTCBB:UVFT), (NASDAQ:JAZZ), (OTCBB:AVXL) Stocks to Watch

Point Roberts, WA –November 12, 2010 (Investorideas.com Newswire and
www.biotechindustrystocks.com) - InvestorIdeas.com, a leader in sector research tools for
investors, features a Biotech /Pharma trading alert featuring Biotech stocks trading up in today’s
trading. With overall markets off, Spectrum Pharmaceuticals, Inc , Anavex Life Sciences Corp.,
and UV Flu Technologies Inc are trading in the green.

Biotech /Pharma Sector Trading Snapshot: (as of time of release November 12th)

UV Flu Technologies, Inc. (OTCBB: UVFT) trading at $0.2825, up 0.0025 (0.89%)
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) trading at $4.58, up 0.16 (3.62%)
Anavex Life Sciences Corp. (OTCBB: AVXL) trading at $4.25, up 0.03 (0.71%)

Market Summary (at time of release)
Dow 11,178.39 -104.71 -0.93%
NASDAQ 2,518.20 -37.32 -1.46%
S&P 500 1,197.62 -15.92 -1.31%
10 Yr Bond(%) 2.7310% +0.0830
Oil 84.85 -2.96 -3.37%
Gold 1,362.50 -40.60 -2.89%

Biotech/Pharma Stocks Recent News;

UV Flu Technologies, Inc. (OTCBB: UVFT) News:
Biotech/Pharma Stocks News; UV Flu Technologies (OTCBB: UVFT) ViraTech UV-400
Featured This Weekend on Nationally Televised Designing Spaces "Holiday Spaces" Show

CENTERVILLE, MA – November 10, 2010 (Investorideas.com Newswire) - UV Flu Technologies,
Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that the Company's ViraTech UV-
400 air purifier technology is featured during "Designing Spaces-Innovations for a Healthy Home
this Holiday Season," scheduled to air on Women's Entertainment (WeTV) this Friday, November
12th, at 9:30 am, EST, and again at the same hour on Sunday the 14th and Monday the 15th.

"I was very excited to participate on the show, particularly with Dr. Dennis Rosen, a Director
of our Company and one of the foremost Pediatricians in the country today, as well as a
real advocate for issues affecting children's health," said Jack Lennon, President of UV Flu
Technology. "We hope to educate the public on the dangers associated with poor indoor air
quality at every opportunity, as we believe it contributes to tens of thousands of deaths and
billions of dollars of health care and lost work expenditures every year. We also wanted to inform
and educate the public of the hazards posed though the use of existing filter based products on
the market today that can cause serious illness if the filters or the electrostatic plates are not
changed or cleaned on a constant basis."
Full Article: http://www.investorideas.com/CO/UVFT/news/11101.asp

About Anavex Life Sciences Corp, (OTCBB: AVXL):
Anavex Life Sciences Corp. (www.anavex.com) is a biopharmaceutical company engaged in the
discovery and development of novel drug candidates for the treatment of neurological diseases
and cancer. The company's proprietary SIGMACEPTOR(TM) Discovery Platform involves
the rational design of drug compounds that are targeted to specific receptors involved in the
modulation of multiple cellular biochemical signaling pathways.

ANAVEX's SIGMACEPTOR(TM)-N program involves the development of novel drug candidates

that target neurological and neurodegenerative diseases (Alzheimer's disease, epilepsy,
depression, pain). The company's lead drug candidates exhibit high affinity for sigma receptors,
which have been extensively documented as potentially valuable drug targets and have
demonstrated anti-amnesic and neuroprotective properties.
Anavex is a publically traded company under the symbol "AVXL".

About Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI):
Spectrum Pharmaceuticals is a biotechnology company with fully integrated commercial and
drug development operations with a primary focus in oncology. The Company’s strategy is
comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-
stage clinical and commercial products. The Company markets two oncology drugs, FUSILEV
and ZEVALIN, and has two drugs, apaziquone and belinostat, in late stage development along
with a diversified pipeline of novel drug candidates. The Company has assembled an integrated
in-house scientific team, including clinical development, medical research, regulatory affairs,
biostatistics and data management, formulation development, and has established a commercial
infrastructure for the marketing of its drug products. The Company also leverages the expertise of
its worldwide partners to assist in the execution of its strategy. For more information, please visit
the Company’s website at www.sppirx.com.

Research other biotech stocks at the Biotech stocks Directory: http://
www.investorideas.com/BIS/Stock_List.asp

About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized
in sector investing, covering leading industry sectors including mining and gold stocks, in addition
to global markets including China, India, the Middle East and Australia. Investorideas.com is
known for its comprehensive stock directories in each sector and sector specific newswires
.

Sign up for free stock alerts on biotech stocks and other leading sectors!

http://www.investorideas.com/Resources/Newsletter.asp

More news - Visit the BPAX showcase profile at Investorideas.com
http://www.investorideas.com/CO/BPAX/
Disclosure, Disclaimer/ BPAX is a paid advertising client on Investorideas.com

About our Biotech investor portal:
www.BiotechIndustryStocks.com is a global meeting place for investors and industry following the
biotech and pharma sector, within Investorideas.com. Global visitors use the site daily to research
the latest news, articles, audio, research reports and our stock directories.

Disclaimer/disclosure : The following news is sponsored for by showcase stocks BPAX
(three thousand per month BPAX) Investorideas.com is a third party publisher of news and
research .Our sites do not make recommendations, but offer information portals to research
news, articles, stock lists and recent research. Nothing on our sites should be construed as an
offer or solicitation to buy or sell products or securities. All investment involves risk and possible
loss of principal. This site is currently compensated by featured companies, news submissions
and online advertising.
More info:
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

No comments:

Post a Comment